Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

被引：0
|
作者：
Hajira Ilyas
N. George Mikhaeel
Joel T. Dunn
Fareen Rahman
Henrik Möller
Daniel Smith
Sally F. Barrington
机构：
[1] Guy’s and St Thomas’ NHS Foundation Trust,Department of Nuclear Medicine
[2] Guy’s and St Thomas’ NHS Foundation Trust,Department of Clinical Oncology
[3] Kings College London at St Thomas’ Hospital,KCL and Guy’s and St Thomas’ PET Centre, School of Biomedical Engineering and Imaging Sciences
[4] Kings Health Partners,Department of Cancer Epidemiology and Population Health
[5] King’s College London,undefined
[6] Kings Health Partners,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：520 / 521
页数：1
相关论文
共 50 条
  • [31] A novel prognostic index for diffuse large B-cell lymphoma combined baseline metabolic tumour volume with clinical and pathological risk factors
    Yuan, T.
    Chen, X.
    Zhang, Y.
    Wei, M.
    Zhu, H.
    Yang, Z.
    Wang, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S302 - S302
  • [32] A novel prognostic index for diffuse large B-cell lymphoma combined baseline metabolic tumour volume with clinical and pathological risk factors
    Yuan, Tingting
    Chen, Xuetao
    Zhang, Yuewei
    Wei, Maomao
    Zhu, Hua
    Yang, Zhi
    Wang, Xuejuan
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (07) : 622 - 630
  • [33] Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?
    Laffon, Eric
    Marthan, Roger
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (10) : 1832 - 1833
  • [34] Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?
    Eric Laffon
    Roger Marthan
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1832 - 1833
  • [35] Association of high baseline metabolic tumor volume with response following axicabtagene ciloleucel in refractory large B-cell lymphoma.
    Dean, Erin
    Lu, Hong
    Lazaryan, Aleksandr
    Krivenko, Gabriel S.
    Bachmeier, Christina A.
    Chavez, Julio C.
    Davila, Marco L.
    Khimani, Farhad
    Liu, Hien D.
    Pinilla-Ibarz, Javier
    Shah, Bijal D.
    Jain, Michael D.
    Balagurunathan, Yoganand
    Locke, Frederick Lundry
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium
    Barrington, Sally F.
    Zwezerijnen, Ben G. J. C.
    de Vet, Henrica C. W.
    Heymans, Martijn W.
    Mikhaeel, N. George
    Burggraaff, Coreline N.
    Eertink, Jakoba J.
    Pike, Lucy C.
    Hoekstra, Otto S.
    Zijlstra, Jose M.
    Boellaard, Ronald
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (03) : 332 - 337
  • [37] Uncovering the metabolic vulnerabilities in activated B cell diffuse large B cell lymphoma
    Singh, Satishkumar
    Choueiry, Fouad
    Sircar, Anuvrat
    Epperla, Narendranath
    Zhu, Jiangjiang
    Sehgal, Lalit
    CANCER RESEARCH, 2023, 83 (07)
  • [38] The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma
    Yamanaka, Shintaro
    Miyagawa, Masao
    Sugawara, Yoshifumi
    Hasebe, Shinji
    Fujii, Tomomi
    Takeuchi, Kazuto
    Tanaka, Keiko
    Yakushijin, Yoshihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 225 - 232
  • [39] A focus on the impact of spleen involvement in total metabolic tumor volume measurements in Diffuse Large B-Cell Lymphoma patients.
    Rebaud, L.
    Capobianco, N.
    Girum, K.
    Cottereau, A.
    Morschhauser, F.
    Spottiswoode, B.
    Buvat, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S559 - S559
  • [40] Metabolic tumor volume on interim PET is a better predictor of outcome in diffuse large B-cell lymphoma than semiquantitative methods
    E Malek
    A Sendilnathan
    M Yellu
    A Petersen
    M Fernandez-Ulloa
    J J Driscoll
    Blood Cancer Journal, 2015, 5 : e326 - e326
12345